Description: Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. The company is headquartered in Mississauga, Canada.
Home Page: www.profoundmedical.com
PROF Technical Analysis
2400 Skymark Avenue
Mississauga,
ON
L4W 5K5
Canada
Phone:
647 476 1350
Officers
| Name | Title |
|---|---|
| Dr. Arun Swarup Menawat MBA, Ph.D. | Chairman & CEO |
| Mr. Rashed Dewan | Chief Financial Officer |
| Dr. Mathieu Burtnyk | Sr. VP of Product Leader TULSA-PRO |
| Mr. Stephen Kilmer | Investor Relations |
| Mr. Hartmut Warnken | Chief Commercial Officer of OUS |
| Mr. Jacques F. Cornet | Sr. VP & Product Leader Sonalleve |
| Mr. Michael Mydra | VP & Head of Global Market Access |
| Mr. Abbey Goodman | Chief Commercial Officer of US |
| Mr. Matthew Sobczyk C.A., CPA | Assistant Corp. Controller |
| Mr. Levant Tinaz | Software Developer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.4719 |
| Price-to-Sales TTM: | 28.6712 |
| IPO Date: | 2016-06-09 |
| Fiscal Year End: | December |
| Full Time Employees: | 146 |